ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

Mark Israel To Direct Norris Cotton Center

October 19, 2001

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

New Jersey Insurers To Cover Patient Care Costs In Trials.

January 14, 2000

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012